Combination of the NRF2 Inhibitor and Autophagy Inhibitor Significantly Inhibited Tumorigenicity of Castration-Resistant Prostate Cancer

Prostate cancer (PCa) is the most frequent cancer in men. Developing new treatment methods for CRPC will be a significant challenge in the clinical treatment of PCa. In conclusion, the results of this study show that NRF2 is downregulated in untreated PCa samples compared to normal PCa samples; howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yong, Xin, Zhixiang, Dong, Baijun, Xue, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236814/
https://www.ncbi.nlm.nih.gov/pubmed/35770119
http://dx.doi.org/10.1155/2022/4182401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236814/
https://www.ncbi.nlm.nih.gov/pubmed/35770119
http://dx.doi.org/10.1155/2022/4182401

Ejemplares similares